{"id":16878,"date":"2021-08-09T13:38:16","date_gmt":"2021-08-09T00:38:16","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=16878"},"modified":"2021-08-16T08:22:39","modified_gmt":"2021-08-15T19:22:39","slug":"cll-and-dermatology","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=16878","title":{"rendered":"CLL and Dermatology"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243;][vc_custom_heading heading_semantic=&#8221;h1&#8243; text_size=&#8221;h1&#8243; uncode_shortcode_id=&#8221;132682&#8243;]<\/p>\n<h1>CLL and Dermatology<\/h1>\n<p>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;149597&#8243;]<\/p>\n<h2>Overview<\/h2>\n<p>More than a quarter of\u00a0<a href=\"https:\/\/patientpower.info\/chronic-lymphocytic-leukemia\/\">CLL<\/a>\u00a0patients experience skin issues. On Thursday, August 12th, at 2 pm PDT\/5 pm EDT, join host Michele Nadeem-Baker and two doctors from\u00a0<a href=\"https:\/\/cancer.osu.edu\/\" target=\"_blank\" rel=\"noopener\">The Ohio State University Comprehensive Cancer Center\u00a0\u2013 The James<\/a>: Jennifer Woyach, MD, hematologist\/oncologist, and Brittany Dulmage, MD, a dermatologist specializing in oncodermatology, for a discussion about CLL and skin. How do skin concerns factor into CLL treatment decisions? What role can a dermatologist play on a patient\u2019s care team? Join us for the answers to these questions and more.<\/p>\n<p><a href=\"https:\/\/patientpower.info\/events\/event\/cll-and-dermatology\/2021-08-12\/1400\/?ap=590&amp;utm_source=e-News+Subscribers&amp;utm_campaign=ff695cf200-EMAIL_CAMPAIGN_12_30_2020_12_41_CLL_US_COPY_01&amp;utm_medium=email&amp;utm_term=0_9e75b45127-ff695cf200-288734757\">https:\/\/patientpower.info\/events\/event\/cll-and-dermatology\/2021-08-12\/1400\/?ap=590&amp;utm_source=e-News+Subscribers&amp;utm_campaign=ff695cf200-EMAIL_CAMPAIGN_12_30_2020_12_41_CLL_US_COPY_01&amp;utm_medium=email&amp;utm_term=0_9e75b45127-ff695cf200-288734757<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>More than a quarter of CLL patients experience skin issues. On Thursday, August 12th, at 2 pm PDT\/5 pm EDT.<\/p>\n","protected":false},"author":1,"featured_media":16879,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12,17,25],"tags":[],"class_list":["post-16878","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","category-featured","category-cllanz-events"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2021\/08\/CLL-Answers-now.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/16878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16878"}],"version-history":[{"count":1,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/16878\/revisions"}],"predecessor-version":[{"id":16880,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/16878\/revisions\/16880"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/16879"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}